Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
Status:
Terminated
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess how well this particular combination of chemotherapy,
radiation and surgery works to help people with locally advanced lung cancer, how well PET
scans indicates whether someone has responded to chemotherapy and radiation, and gene
expression patterns related to outcomes in patients with locally advanced lung cancer who
receive this treatment regimen.